| The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. V Brichard, A Van Pel, T Wölfel, C Wölfel, E De Plaen, B Lethé, P Coulie, ... The Journal of experimental medicine 178 (2), 489-495, 1993 | 1150 | 1993 |
| A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. PG Coulie, V Brichard, A Van Pel, T Wölfel, J Schneider, C Traversari, ... The Journal of experimental medicine 180 (1), 35-42, 1994 | 1119 | 1994 |
| Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE‐3 and presented by HLA‐A1 M Marchand, N Van Baren, P Weynants, V Brichard, B Dréno, MH Tessier, ... International journal of cancer 80 (2), 219-230, 1999 | 1027 | 1999 |
| Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas J Van Snick, S Cayphas, A Vink, C Uyttenhove, PG Coulie, MR Rubira, ... Proceedings of the National Academy of Sciences 83 (24), 9679-9683, 1986 | 798 | 1986 |
| Human T cell responses against melanoma T Boon, PG Coulie, BJV Eynde, P Bruggen Annu. Rev. Immunol. 24, 175-208, 2006 | 762 | 2006 |
| Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor H Ikeda, B Lethé, F Lehmann, N Van Baren, JF Baurain, C De Smet, ... Immunity 6 (2), 199-208, 1997 | 741 | 1997 |
| Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy PG Coulie, BJ Van den Eynde, P Van Der Bruggen, T Boon Nature Reviews Cancer 14 (2), 135-146, 2014 | 734 | 2014 |
| BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes P Boël, C Wildmann, ML Sensi, R Brasseur, JC Renauld, P Coulie, ... Immunity 2 (2), 167-175, 1995 | 725 | 1995 |
| Tumor antigens recognized by T cells T Boon, PG Coulie, B Van den Eynde Immunology today 18 (6), 267-268, 1997 | 658 | 1997 |
| Guidelines for the use of flow cytometry and cell sorting in immunological studies A Cossarizza, HD Chang, A Radbruch, M Akdis, I Andrä, F Annunziato, ... European journal of immunology 47 (10), 1584-1797, 2017 | 579 | 2017 |
| A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma PG Coulie, F Lehmann, B Lethe, J Herman, C Lurquin, M Andrawiss, ... Proceedings of the National Academy of Sciences 92 (17), 7976-7980, 1995 | 443 | 1995 |
| A peptide encoded by human gene MAGE‐3 and presented by HLA‐A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE‐3 P van der Bruggen, J Bastin, T Gajewski, PG Coulie, P Boël, C De Smet, ... European journal of immunology 24 (12), 3038-3043, 1994 | 442 | 1994 |
| The determinants of tumour immunogenicity T Blankenstein, PG Coulie, E Gilboa, EM Jaffee Nature Reviews Cancer 12 (4), 307-313, 2012 | 311 | 2012 |
| T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor. C Uyttenhove, PG Coulie, J Van Snick The Journal of experimental medicine 167 (4), 1417-1427, 1988 | 300 | 1988 |
| A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia H Dolstra, H Fredrix, F Maas, PG Coulie, F Brasseur, E Mensink, ... The Journal of experimental medicine 189 (2), 301-308, 1999 | 285 | 1999 |
| Genes coding for tumor antigens recognized by cytolytic T lymphocytes A Van Pel, P Van Der Bruggen, PG Coulie, VG Brichard, B Lethe Immunological reviews 145, 229-250, 1995 | 281 | 1995 |
| A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3 PG Coulie, V Karanikas, D Colau, C Lurquin, C Landry, M Marchand, ... Proceedings of the National Academy of Sciences 98 (18), 10290-10295, 2001 | 274 | 2001 |
| Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients J Tel, EHJG Aarntzen, T Baba, G Schreibelt, BM Schulte, D Benitez-Ribas, ... Cancer research 73 (3), 1063-1075, 2013 | 270 | 2013 |
| Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen C Lurquin, B Lethé, E De Plaen, V Corbière, I Théate, N Van Baren, ... The Journal of experimental medicine 201 (2), 249-257, 2005 | 262 | 2005 |
| Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection F Lehmann, M Marchand, P Hainaut, P Pouillart, X Sastre, H Ikeda, ... European journal of immunology 25 (2), 340-347, 1995 | 262 | 1995 |
